Envoy Medical, Inc. (COCH)

Envoy Medical Statistics

Total Valuation

Envoy Medical has a market cap or net worth of $43.53 million. The enterprise value is $54.71 million.

Market Cap	43.53M
Enterprise Value	54.71M

Important Dates

The last earnings date was Thursday, November 14, 2024, after market close.

Earnings Date	Nov 14, 2024
Ex-Dividend Date	n/a

Share Statistics

Envoy Medical has 20.24 million shares outstanding. The number of shares has increased by 93.59% in one year.

Current Share Class	20.24M
Shares Outstanding	20.24M
Shares Change (YoY)	+93.59%
Shares Change (QoQ)	+0.08%
Owned by Insiders (%)	39.57%
Owned by Institutions (%)	6.74%
Float	7.71M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	151.91
Forward PS	89.86
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	196.80
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.79

Current Ratio	0.79
Quick Ratio	0.51
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-49.69

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-87.66%
Return on Capital (ROIC)	-1,093.02%
Revenue Per Employee	$8,176
Profits Per Employee	-$740,235
Employee Count	34
Asset Turnover	0.02
Inventory Turnover	0.54

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +136.26% in the last 52 weeks. The beta is 2.36, so Envoy Medical's price volatility has been higher than the market average.

Beta (5Y)	2.36
52-Week Price Change	+136.26%
50-Day Moving Average	2.72
200-Day Moving Average	3.22
Relative Strength Index (RSI)	43.33
Average Volume (20 Days)	680,116

Short Selling Information

The latest short interest is 46,876, so 0.23% of the outstanding shares have been sold short.

Short Interest	46,876
Short Previous Month	44,111
Short % of Shares Out	0.23%
Short % of Float	0.61%
Short Ratio (days to cover)	1.75

Income Statement

In the last 12 months, Envoy Medical had revenue of $278,000 and -$25.17 million in losses. Loss per share was -$1.28.

Revenue	278,000
Gross Profit	-541,000
Operating Income	-21.47M
Pretax Income	-23.04M
Net Income	-25.17M
EBITDA	-21.29M
EBIT	-21.47M
Loss Per Share	-$1.28

Balance Sheet

The company has $4.42 million in cash and $15.61 million in debt, giving a net cash position of -$11.19 million or -$0.55 per share.

Cash & Cash Equivalents	4.42M
Total Debt	15.61M
Net Cash	-11.19M
Net Cash Per Share	-$0.55
Equity (Book Value)	-18.53M
Book Value Per Share	-0.94
Working Capital	-1.94M

Cash Flow

In the last 12 months, operating cash flow was -$25.27 million and capital expenditures -$1.54 million, giving a free cash flow of -$26.80 million.

Operating Cash Flow	-25.27M
Capital Expenditures	-1.54M
Free Cash Flow	-26.80M
FCF Per Share	-$1.32

Margins

Gross Margin	-194.60%
Operating Margin	-7,721.94%
Pretax Margin	-7,574.82%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-7,266.81%

Dividends & Yields

Envoy Medical does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-93.59%
Shareholder Yield	-93.59%
Earnings Yield	-57.82%
FCF Yield	-61.58%

Analyst Forecast

The average price target for Envoy Medical is $7.92, which is 268.37% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$7.92
Price Target Difference	268.37%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Envoy Medical has an Altman Z-Score of -47.91. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-47.91
Piotroski F-Score	n/a